These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12773886)

  • 1. Multiple system atrophy.
    Wenning GK; Geser F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S31-8. PubMed ID: 12773886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple system atrophy: pathophysiology and management.
    Wenning GK; Braune S
    CNS Drugs; 2001; 15(11):839-52. PubMed ID: 11700149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism. Multiple system atrophy.
    Wenning GK; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):187-204. PubMed ID: 9426875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple system atrophy].
    Damon-Perrière N; Tison F; Meissner WG
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):179-91. PubMed ID: 20739256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of multiple system atrophy].
    Wenning GK; Seppi K
    Praxis (Bern 1994); 2001 Jun; 90(23):1035-40. PubMed ID: 11447723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies in multiple system atrophy.
    Wenning GK; Geser F; Poewe W
    Mov Disord; 2005 Aug; 20 Suppl 12():S67-76. PubMed ID: 16092094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo models of multiple system atrophy.
    Fernagut PO; Ghorayeb I; Diguet E; Tison F
    Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau-positive glial cytoplasmic granules in multiple system atrophy.
    Nagaishi M; Yokoo H; Nakazato Y
    Neuropathology; 2011 Jun; 31(3):299-305. PubMed ID: 21062361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential outcome measures and trial design issues for multiple system atrophy.
    May S; Gilman S; Sowell BB; Thomas RG; Stern MB; Colcher A; Tanner CM; Huang N; Novak P; Reich SG; Jankovic J; Ondo WG; Low PA; Sandroni P; Lipp A; Marshall FJ; Wooten F; Shults CW;
    Mov Disord; 2007 Dec; 22(16):2371-7. PubMed ID: 17914727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of neuronal degeneration of multiple system atrophy].
    Yoshida M; Sone M
    Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging.
    da Rocha AJ; Maia AC; da Silva CJ; Braga FT; Ferreira NP; Barsottini OG; Ferraz HB
    Mov Disord; 2007 Jan; 22(2):238-44. PubMed ID: 17133514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple system atrophy--update].
    Sasaki H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):979-81. PubMed ID: 15651348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple system atrophy: clinical presentation and diagnosis.
    Austin MT; Davis TL; Robertson D; Charles PD
    Tenn Med; 1999 Feb; 92(2):55-7. PubMed ID: 9932532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based volumetric differentiation of sporadic cerebellar ataxia.
    Burk K; Globas C; Wahl T; Bühring U; Dietz K; Zuhlke C; Luft A; Schulz JB; Voigt K; Dichgans J
    Brain; 2004 Jan; 127(Pt 1):175-81. PubMed ID: 14570820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.